Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Elon Musk Pipped By Maverick Founder Larry Ellison Who Once Eyed Apple; Oracle Stocks Sizzle

Elon Musk Pipped By Maverick Founder Larry Ellison Who Once Eyed Apple; Oracle Stocks Sizzle

Indian Millennials Are Different From APAC Ones, They Prefer Family Trips

Indian Millennials Are Different From APAC Ones, They Prefer Family Trips

Rupee As THE New Reserve Currency? CEA Nageswaran Clarifies

Rupee As THE New Reserve Currency? CEA Nageswaran Clarifies

Stop Dreaming About That iPhone, Instead Look At This Stock For Sweet Gains

Stop Dreaming About That iPhone, Instead Look At This Stock For Sweet Gains

Nepal on boil, India Inc's turmoil; Hilton Kathmandu Set Ablaze

Nepal on boil, India Inc's turmoil; Hilton Kathmandu Set Ablaze